CDK2 and cancer: DGCs in ZEA treatment, another four genes involved in anti-oncogene process downregulating were also identified, such as PTEN, TGFβ, CDK2, and ATM. Finally, CCND2, CDK6, TNF, and TP53 genes in treatment dGCs, were identified involving in cancer process either upregulation or downregulation.